Patrick Baeuerle

Company: Cullinan Oncology

Job title: Chief Scientific Officer

Seminars:

Noval Modalities: A Review 9:00 am - 12:00 pm

The three approved cell engager antibodies currently available all have different engagers, different targets and different formats. Indicating that there is no one specific playbook to follow. Additionally, this also evidences that there is a lot of innovation taking place in the space. In this session, we will see examples of these modalities and hear…Read more

day: Pre-Conference Day Track A